Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| EW | Markowitz Wayne | CVP, JAPAC | 07/28/2026 | Verkauf | 85.06 | 9,628 | 818,958 | Form 4 |
| EW | Markowitz Wayne | CVP, JAPAC | 07/28/2026 | Optionsausübung | 74.02 | 9,628 | 712,665 | Form 4 |
| CVBF | O Brien Raymond V III | Director | 07/28/2026 | Kauf | 22.77 | 20,000 | 455,300 | Form 4 |
| CNC | Diaz Paul J | Director | 07/28/2026 | Zuteilung | — | 2,771 | — | Form 4 |
| BYRN | Hughes Herbert | Director | 07/28/2026 | Kauf | 3.86 | 1,499 | 5,791 | Form 4 |
| BFAM | Burke Mary Lou | COO North America Center Ops | 07/28/2026 | Verkauf | 80.00 | 500 | 40,000 | Form 4 |
| BYD | Hirsberg Josh | CFO & Treasurer | 07/28/2026 | Verkauf | 89.76 | 12,777 | 1,146,864 | Form 4 |
| NHI | Maingot Christian Ken | Chief Operating Officer | 07/27/2026 | Zuteilung | — | 2,370 | — | Form 4 |
| SOPH | Menu Philippe | Chief Medical Officer | 07/27/2026 | Verkauf | 5.66 | 5,000 | 28,306 | Form 4 |
| WEX | Kimball Jennifer | Chief Accounting Officer | 07/27/2026 | Verkauf | 176.55 | 1,183 | 208,859 | Form 4 |
| WEX | Drew Ann Elena | Chief Risk and Compliance | 07/27/2026 | Verkauf | 176.02 | 3,400 | 598,468 | Form 4 |
| VMI | Freye Theodor Werner | Director | 07/27/2026 | Verkauf | 495.00 | 800 | 396,000 | Form 4 |
| REAL | McKeehan Jennifer | Director | 07/27/2026 | Zuteilung | — | 14,150 | — | Form 4 |
| REAL | McCaffrey Mark | Director | 07/27/2026 | Zuteilung | — | 14,150 | — | Form 4 |
| REAL | Coleman Caretha | Director | 07/27/2026 | Zuteilung | — | 14,150 | — | Form 4 |
| REAL | Miller James R. | Director | 07/27/2026 | Zuteilung | — | 14,150 | — | Form 4 |
| REAL | Krolik Robert J | Director | 07/27/2026 | Zuteilung | — | 14,150 | — | Form 4 |
| REAL | Katz Karen | Director | 07/27/2026 | Zuteilung | — | 14,150 | — | Form 4 |
| TMP | Torcello Diane D | EVP & President, Tompkins WNY | 07/27/2026 | Steuer-Abgabe | 99.68 | 214 | 21,332 | Form 4 |
| TMP | Torcello Diane D | EVP & President, Tompkins WNY | 07/27/2026 | Optionsausübung | 76.90 | 250 | 19,225 | Form 4 |
| SFIX | Bacos Anthony | Chief Prod/Technology Officer | 07/27/2026 | Verkauf | 3.74 | 20,000 | 74,778 | Form 4 |
| SFIX | Bacos Anthony | Chief Prod/Technology Officer | 07/27/2026 | Verkauf | 3.77 | 50,000 | 188,705 | Form 4 |
| SFIX | Bacos Anthony | Chief Prod/Technology Officer | 07/27/2026 | Optionsausübung | 2.48 | 50,000 | 124,000 | Form 4 |
| IOT | Eltoukhy Adam | SEE REMARKS | 07/27/2026 | Verkauf | 35.73 | 1,439 | 51,416 | Form 4 |
| IOT | Eltoukhy Adam | SEE REMARKS | 07/27/2026 | Verkauf | 34.44 | 2,214 | 76,248 | Form 4 |
| SOTK | Bagley Stephen James | CFO | 07/27/2026 | Verkauf | 5.08 | 1,200 | 6,090 | Form 4 |
| SCHW | Murtagh Nigel J | Chief Risk Officer | 07/27/2026 | Verkauf | 104.03 | 11,000 | 1,144,349 | Form 4 |
| SCHW | Murtagh Nigel J | Chief Risk Officer | 07/27/2026 | Verkauf | 104.00 | 21,947 | 2,282,488 | Form 4 |
| SCHW | Murtagh Nigel J | Chief Risk Officer | 07/27/2026 | Optionsausübung | 46.81 | 32,947 | 1,542,249 | Form 4 |
| SCHW | Bettinger Walter W | Co-Chairman | 07/27/2026 | Verkauf | 103.90 | 192,488 | 19,999,927 | Form 4 |
| SCHW | Bettinger Walter W | Co-Chairman | 07/27/2026 | Optionsausübung | 52.05 | 192,488 | 10,019,000 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 07/27/2026 | Verkauf | 34.95 | 200,000 | 6,990,000 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 07/27/2026 | Optionsausübung | 3.85 | 200,000 | 770,000 | Form 4 |
| RAPP | Ceesay Abraham | Chief Executive Officer | 07/27/2026 | Verkauf | 42.74 | 7 | 299 | Form 4 |
| RAPP | Ceesay Abraham | Chief Executive Officer | 07/27/2026 | Verkauf | 42.11 | 2,203 | 92,762 | Form 4 |
| AIOT | Towe Steven Mark | Chief Executive Officer | 07/27/2026 | Steuer-Abgabe | 4.42 | 48,959 | 216,399 | Form 4 |
| AIOT | Towe Steven Mark | Chief Executive Officer | 07/27/2026 | Steuer-Abgabe | 4.42 | 27,313 | 120,723 | Form 4 |
| AIOT | Ingram Melissa Rose | See remarks | 07/27/2026 | Steuer-Abgabe | 4.42 | 12,018 | 53,120 | Form 4 |
| AIOT | Wilson David | Chief Financial Officer | 07/27/2026 | Steuer-Abgabe | 4.42 | 13,250 | 58,565 | Form 4 |
| PPIH | Lewicki Matthew Earl | Chief Financial Officer | 07/27/2026 | Steuer-Abgabe | 25.44 | 898 | 22,845 | Form 4 |
| POOL | Saik Walker | Chief Accounting Officer | 07/27/2026 | Steuer-Abgabe | 184.61 | 22 | 4,061 | Form 4 |
| PEP | Flavell David | EVP, Gen Counsel & Corp Sec | 07/27/2026 | Verkauf | 139.54 | 2,900 | 404,674 | Form 4 |
| TOI | Kaushal Mohit | Director | 07/27/2026 | Zuteilung | — | 33,133 | — | Form 4 |
| TOI | McGeorge Anne | Director | 07/27/2026 | Zuteilung | — | 41,165 | — | Form 4 |
| TOI | Pacala Mark L | Director | 07/27/2026 | Zuteilung | — | 30,120 | — | Form 4 |
| TOI | Stolper Mark | Director | 07/27/2026 | Zuteilung | — | 31,124 | — | Form 4 |
| TOI | Tzoumakas Kimberly Jo | Director | 07/27/2026 | Zuteilung | — | 29,116 | — | Form 4 |
| TOI | Hively Brad | Director | 07/27/2026 | Zuteilung | — | 27,108 | — | Form 4 |
| TOI | Johnson Karen Marie | Director | 07/27/2026 | Zuteilung | — | 31,124 | — | Form 4 |
| NTRA | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 07/27/2026 | Verkauf | 260.49 | 782 | 203,704 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 07/27/2026 | Verkauf | 260.49 | 1,010 | 263,096 | Form 4 |
| NTRA | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | 07/27/2026 | Verkauf | 260.49 | 884 | 230,274 | Form 4 |
| NTRA | Chapman Steven Leonard | CEO AND PRESIDENT | 07/27/2026 | Verkauf | 260.49 | 2,190 | 570,475 | Form 4 |
| NTRA | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 07/27/2026 | Verkauf | 260.49 | 782 | 203,704 | Form 4 |
| NTRA | Sheena Jonathan | Director | 07/27/2026 | Verkauf | 260.49 | 288 | 75,021 | Form 4 |
| NTRA | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 07/27/2026 | Verkauf | 260.49 | 1,718 | 447,523 | Form 4 |
| NNOX | Suesskind Dan S | Director | 07/27/2026 | Kauf | 0.92 | 25,000 | 23,000 | Form 4 |
| NVEC | Baker Daniel A | President & CEO | 07/27/2026 | Verkauf | 117.56 | 1,518 | 178,456 | Form 4 |
| NVEC | Baker Daniel A | President & CEO | 07/27/2026 | Optionsausübung | 117.55 | 1,061 | 124,721 | Form 4 |
| NVEC | Baker Daniel A | President & CEO | 07/27/2026 | Optionsausübung | 117.55 | 757 | 88,985 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).